Former Alnylam CEO appointed new chair of Hemab
Biotech company Hemab starts the year by welcoming two new faces to the board, including former Alnylam CEO John Maraganore as chair. Hemab also appoints a new member to leadership.
by CHRISTOPHER DUE KARLSSON, translated by daniel pedersen
On Wednesday, biotech company Hemab presented a string of new people who will soon join either Hemab's board of directors or the company's management, as reported in a in a press release.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
